HONOLULU, HI, UNITED STATES, January 27, 2026 /EINPresswire.com/ -- Pioneering Change in Aviation Education and ...

Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance ...

Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.

Inspire Medical Systems (NYSE:INSP) management focused much of its fourth-quarter and full-year 2025 earnings call on reimbursement and coding uncertainty tied to the company’s Inspire 5 system, while ...

MINNEAPOLIS - Inspire Medical Systems, Inc. (NYSE:INSP) reported fourth quarter earnings that beat analyst expectations, but shares tumbled 8.7% as the company disclosed a coding clarification that ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2025 results , with sales up 12.2% year on year to $269.1 million. On the other hand, the company’s full-year revenue ...

Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.

In less than 90 minutes, a new, less invasive electrical stimulation technique has been found to improve breathing in people with sleep apnea. The technique, which involves percutaneous hypoglossal ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Please provide your email address to receive an email when new articles are posted on . A higher proportion of adults with insomnia and sleep apnea had uncontrolled hypertension vs. those with only ...

A new pill could change the landscape for sleep apnea treatment. The condition affects some 30 million Americans, according to the AMA. Currently, the most commonly prescribed treatment is the widely ...